Sort
85,873 grants matching “alzheimers”
Extracellular Vesicle treatment and age-related neuropathology in non-human primates
$802,973Tara L Moore · Boston University Medical Campus · R01 · FY2021 · AG
CommunityRx-Dementia
$802,934Stacy Tessler Lindau · University Of Chicago · R01 · FY2019 · AG
Emotion alterations across the Alzheimer's disease spectrum
$802,920Virginia Emily Sturm · University Of California, San Francisco · R01 · FY2022 · AG
Control of Cholesterol Metabolism --Bile Acid Transport
$802,901University Of Texas Sw Med Ctr/Dallas · R01 · FY2005 · HL
Elucidating endolysosomal trafficking dysregulation induced by APOE4 in human astrocytes
$802,834Julia Tcw · Boston University Medical Campus · R01 · FY2024 · AG
Risk for Later-Life Cognitive Impairment, Neurobehavioral Dysregulation, and Dementia in Former Soccer and American Football Players: The Head Impact and Trauma Surveillance Study (HITSS)
$802,832Robert A Stern · Boston University Medical Campus · R01 · FY2022 · NS
Age-related Hypertension and Vascular Cognitive Impairment
$802,742Richard David Wainford · Boston University Medical Campus · R01 · FY2023 · AG
Administration Core
$802,655David M Holtzman · Washington University · P30 · FY2023 · AG
National Cohort Studies of Alzheimer's Disease, Related Dementias and Air Pollution
$802,617Antonella Zanobetti · Harvard School Of Public Health · R01 · FY2020 · AG
QUANTITATIVE MRI AND 1H-MRS IN TRAUMATIC BRAIN INJURY
$802,504New York University School Of Medicine · R01 · FY2002 · NS
A Technology-Based Novel Functional Skills Assessment and Training Program for Adults with and without Cognitive Impairments. Develop the next generation software solution.
$802,500Peter Kallestrup · I-Function, Inc. · R44 · FY2020 · AG
Identifying cell type-specific autonomous and non-autonomous interactions in AD
$802,494Vilas Menon · Columbia University Health Sciences · R01 · FY2025 · AG
Sigma-1 Receptor Radioligand for Translational Research in Alzheimer's Disease
$802,472Yiyun Henry Huang · Yale University · R01 · FY2025 · AG
Regulation of tau expression in Alzheimer disease and aging
$802,350John Fonda Crary · Icahn School Of Medicine At Mount Sinai · R01 · FY2019 · AG
Regulation of tau expression in Alzheimer disease and aging
$802,350John Fonda Crary · Icahn School Of Medicine At Mount Sinai · R01 · FY2020 · AG
Imaging Mass Spectrometry-Based Metabolomic Analysis of the Alzheimer's Brain
$802,288Valina L. Dawson · Johns Hopkins University · R01 · FY2025 · AG
Targeted disruption the enzymes of O-GlcNAc cycling: Animal models of Disease
$802,279John A. Hanover · National Institute Of Diabetes And Digestive And Kidney Diseases · ZIA · FY2015 · DK
The role of immune deregulation and NGF dysmetabolism in the development of Alzheimer disease in individuals with Down syndrome
$802,150Jorge A Busciglio · University Of California-Irvine · R01 · FY2025 · AG
Neurodevelopment in children from families with genetic frontotemporal dementia and Alzheimerâs disease
$802,137Suzee Eurie Lee · University Of California, San Francisco · R01 · FY2022 · AG
ADNI Psychometrics
$802,123Paul K Crane · University Of Washington · R01 · FY2017 · AG
Role of LRP1 in Alzheimerâs disease
$802,111Young-Bum Kim · Beth Israel Deaconess Medical Center · R01 · FY2025 · AG
HUCBC modulation of Alzheimer's-like pathology and behavioral changes
$802,085Jun Tan · Saneron Ccel Therapeutics, Inc. · R42 · FY2012 · AG
Role of Telomere And Telomerase In Human Lymphocyte Function and Aging
$802,045Nan Ping Weng · Aging · Z01 · FY2007 · AG
A Multimodal, Multiscale and Multistage Systems Biology (M3SB) Infrastructure for Precision Medicine in Alzheimerâs Disease and Longevity
$802,034Feixiong Cheng · Cleveland Clinic Lerner Com-Cwru · R01 · FY2025 · AG
An Integrative Computational Multimodal approach to disentangle Pathophysiologic Heterogeneity of age-related White Matter Hyperintensities
$802,017Chia-Ling Phuah · St. Joseph'S Hospital And Medical Center · R01 · FY2024 · AG